339 related articles for article (PubMed ID: 37258589)
1. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.
Kim JW; Min DW; Kim D; Kim J; Kim MJ; Lim H; Lee JY
Sci Rep; 2023 May; 13(1):8872. PubMed ID: 37258589
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
3. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial ROS induced by ML385, an Nrf2 inhibitor aggravates the ferroptosis induced by RSL3 in human lung epithelial BEAS-2B cells.
Taufani IP; Situmorang JH; Febriansah R; Tasminatun S; Sunarno S; Yang LY; Chiang YT; Huang CY
Hum Exp Toxicol; 2023; 42():9603271221149663. PubMed ID: 36625148
[TBL] [Abstract][Full Text] [Related]
5. Slowly progressive cell death induced by GPx4-deficiency occurs via MEK1/ERK2 activation as a downstream signal after iron-independent lipid peroxidation.
Tsuruta K; Matsuoka M; Harada S; Enomoto A; Kumagai T; Yasuda S; Koumura T; Yamada KI; Imai H
J Clin Biochem Nutr; 2024 Mar; 74(2):97-107. PubMed ID: 38510679
[TBL] [Abstract][Full Text] [Related]
6. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
[TBL] [Abstract][Full Text] [Related]
7. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
Dächert J; Schoeneberger H; Rohde K; Fulda S
Oncotarget; 2016 Sep; 7(39):63779-63792. PubMed ID: 27588473
[TBL] [Abstract][Full Text] [Related]
8. [Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].
Cheng L; Jin X; Lu WY; Sun R; Cao YQ; Wei YX; Wang LQ; He XY; Yuan T; Meng JX; Zhao MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1109-1118. PubMed ID: 34362489
[TBL] [Abstract][Full Text] [Related]
9. Exogenous 1,25(OH)
Cheng K; Yang G; Huang M; Huang Y; Wang C
Chem Biol Interact; 2024 Jan; 387():110828. PubMed ID: 38081571
[TBL] [Abstract][Full Text] [Related]
10. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer.
Sui X; Zhang R; Liu S; Duan T; Zhai L; Zhang M; Han X; Xiang Y; Huang X; Lin H; Xie T
Front Pharmacol; 2018; 9():1371. PubMed ID: 30524291
[TBL] [Abstract][Full Text] [Related]
11. Theaflavin-3,3'-Digallate Inhibits Erastin-Induced Chondrocytes Ferroptosis via the Nrf2/GPX4 Signaling Pathway in Osteoarthritis.
Xu C; Ni S; Xu N; Yin G; Yu Y; Zhou B; Zhao G; Wang L; Zhu R; Jiang S; Wang Y
Oxid Med Cell Longev; 2022; 2022():3531995. PubMed ID: 36439689
[TBL] [Abstract][Full Text] [Related]
12. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial event as an ultimate step in ferroptosis.
Oh SJ; Ikeda M; Ide T; Hur KY; Lee MS
Cell Death Discov; 2022 Oct; 8(1):414. PubMed ID: 36209144
[TBL] [Abstract][Full Text] [Related]
14. [MACC1 knockdown enhances RSL3-induced ferroptosis in human colorectal cancer cells by inhibiting GPX4 expression].
Sun S; Huang X; Li G; Zhang C; Lu Z; Zhang W; Li Z; Yang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):173-178. PubMed ID: 38293989
[TBL] [Abstract][Full Text] [Related]
15. Silencing TRPM2 enhanced erastin- and RSL3-induced ferroptosis in gastric cancer cells through destabilizing HIF-1α and Nrf2 proteins.
Li D; Wang T; Lai J; Zeng D; Chen W; Zhang X; Zhu X; Zhang G; Hu Z
Cytotechnology; 2022 Oct; 74(5):559-577. PubMed ID: 36238268
[TBL] [Abstract][Full Text] [Related]
16. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
17. Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells.
Cai S; Ding Z; Liu X; Zeng J
Chem Biol Interact; 2023 Jan; 369():110262. PubMed ID: 36396105
[TBL] [Abstract][Full Text] [Related]
18. A novel anticancer property of
DU X; Zhang J; Liu L; Xu B; Han H; Dai W; Pei X; Fu X; Hou S
J Zhejiang Univ Sci B; 2022 Apr; 23(4):286-299. PubMed ID: 35403384
[TBL] [Abstract][Full Text] [Related]
19. Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.
Park SY; Jeong KJ; Poire A; Zhang D; Tsang YH; Blucher AS; Mills GB
Cell Death Dis; 2023 Aug; 14(8):532. PubMed ID: 37596261
[TBL] [Abstract][Full Text] [Related]
20. Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma.
Yangyun W; Guowei S; Shufen S; Jie Y; Rui Y; Yu R
Gene; 2022 Jan; 809():145992. PubMed ID: 34648917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
